APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial

INTRODUCTION: Relationships between apolipoprotein L1 gene (APOL1) renal-risk variants (RRVs) and cardiovascular disease (CVD) remain controversial. To clarify associations between APOL1 and CVD, a total of 2568 African American Systolic Blood Pressure Intervention Trial (SPRINT) participants were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, Barry I., Rocco, Michael V., Bates, Jeffrey T., Chonchol, Michel, Hawfield, Amret T., Lash, James P., Papademetriou, Vasilios, Sedor, John R., Servilla, Karen, Kimmel, Paul L., Wall, Barry M., Pajewski, Nicholas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527675/
https://www.ncbi.nlm.nih.gov/pubmed/28758155
http://dx.doi.org/10.1016/j.ekir.2017.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527675/
https://www.ncbi.nlm.nih.gov/pubmed/28758155
http://dx.doi.org/10.1016/j.ekir.2017.03.008

Ejemplares similares